These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27006280)

  • 1. Compromised in vitro dissolution and membrane transport of multidrug amorphous formulations.
    Alhalaweh A; Bergström CAS; Taylor LS
    J Control Release; 2016 May; 229():172-182. PubMed ID: 27006280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution performance of binary amorphous drug combinations--Impact of a second drug on the maximum achievable supersaturation.
    Trasi NS; Taylor LS
    Int J Pharm; 2015 Dec; 496(2):282-90. PubMed ID: 26456250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic understanding of the phase behavior of supersaturated solutions of poorly water-soluble drugs.
    Tres F; Posada MM; Hall SD; Mohutsky MA; Taylor LS
    Int J Pharm; 2018 May; 543(1-2):29-37. PubMed ID: 29572154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Simulated Intestinal Fluids on Dissolution, Solution Chemistry, and Membrane Transport of Amorphous Multidrug Formulations.
    El Sayed M; Alhalaweh A; Bergström CAS
    Mol Pharm; 2021 Nov; 18(11):4079-4089. PubMed ID: 34613730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relevance of co-amorphous formulations to develop supersaturated dosage forms: In-vitro, and ex-vivo investigation of Ritonavir-Lopinavir co-amorphous materials.
    Sai Krishna Anand V; Sakhare SD; Navya Sree KS; Nair AR; Raghava Varma K; Gourishetti K; Dengale SJ
    Eur J Pharm Sci; 2018 Oct; 123():124-134. PubMed ID: 30048798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug, Anti-HIV Amorphous Solid Dispersions: Nature and Mechanisms of Impacts of Drugs on Each Other's Solution Concentrations.
    Arca HÇ; Mosquera-Giraldo LI; Dahal D; Taylor LS; Edgar KJ
    Mol Pharm; 2017 Nov; 14(11):3617-3627. PubMed ID: 28872867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HIV drugs, lopinavir/ritonavir and atazanavir, modulate innate immune response triggered by Leishmania in macrophages: the role of NF-κB and PPAR-γ.
    Alves ÉAR; de Miranda MG; Borges TK; Magalhães KG; Muniz-Junqueira MI
    Int Immunopharmacol; 2015 Feb; 24(2):314-324. PubMed ID: 25545854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into Amorphous Solid Dispersion Performance by Coupled Dissolution and Membrane Mass Transfer Measurements.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Mol Pharm; 2019 Jan; 16(1):448-461. PubMed ID: 30521350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of ritonavir formulations and correlation to in vivo performance in dogs.
    Xu H; Krakow S; Shi Y; Rosenberg J; Gao P
    Eur J Pharm Sci; 2018 Mar; 115():286-295. PubMed ID: 29355594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting the Phenomenon of Liquid-Liquid Phase Separation for Enhanced and Sustained Membrane Transport of a Poorly Water-Soluble Drug.
    Indulkar AS; Gao Y; Raina SA; Zhang GG; Taylor LS
    Mol Pharm; 2016 Jun; 13(6):2059-69. PubMed ID: 27138900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailoring supersaturation from amorphous solid dispersions.
    Li N; Taylor LS
    J Control Release; 2018 Jun; 279():114-125. PubMed ID: 29654798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic and health-related quality-of-life (HRQoL) comparison of lopinavir/ritonavir (LPV/r) and atazanavir plus ritonavir (ATV+RTV) based regimens for antiretroviral therapy (ART)-naïve and -experienced United Kingdom patients in 2011.
    Simpson KN; Baran RW; Collomb D; Beck EJ; Van de Steen O; Dietz B
    J Med Econ; 2012; 15(4):796-806. PubMed ID: 22563716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
    Schver GCRM; Lee PI
    Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S; Cathcart H; O'Reilly NJ
    Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamics of Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs-Impact of a Second Drug on the Solution Phase Behavior and Implications for Combination Products.
    Trasi NS; Taylor LS
    J Pharm Sci; 2015 Aug; 104(8):2583-93. PubMed ID: 26059413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions.
    Ashwathy P; Anto AT; Sudheesh MS
    Drug Dev Ind Pharm; 2021 Jan; 47(1):1-11. PubMed ID: 33494623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Micellar Surfactant on Supersaturation and Insight into Solubilization Mechanisms in Supersaturated Solutions of Atazanavir.
    Indulkar AS; Mo H; Gao Y; Raina SA; Zhang GGZ; Taylor LS
    Pharm Res; 2017 Jun; 34(6):1276-1295. PubMed ID: 28352994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.